Exodos Life Science Partners
Recent Finacing
Equity
Recent Raise
$0.3M
Exodos develops ELS115, a ketoprofen topical using Apricus’s NexACT biodegradable excipient delivery to enhance skin penetration for localized pain relief, pursuing an FDA 505(b)(2) pathway and IND submission.
Highlights
Focus Areas
Biotechnology
Life Science
Pharmaceutical
Financials
$0.3M
Total Raised
1
Funding round